Treatments How It Works Team Pricing Hospitals About FAQ Consult Now
Home  /  Treatments  /  Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma Treatment in China

IMRT-based treatment courses from $10,000–25,000 — in the country where the disease is most studied and most frequently treated.

Radiotherapy treatment facility in China
The Basics

What NPC treatment involves

Nasopharyngeal carcinoma (NPC) is a cancer of the upper throat that behaves very differently from other head and neck cancers: it is strongly associated with Epstein-Barr virus, it responds well to radiation, and it is concentrated in southern China — Guangdong province in particular has one of the highest incidence rates in the world. Because of that, Chinese radiation-oncology departments treat a very large number of these cases every year.

The standard of care for most stages is intensity-modulated radiotherapy (IMRT) — highly conformal radiation that spares the salivary glands, eyes and brainstem — with concurrent chemotherapy for more advanced disease. A course is usually delivered daily over roughly six to seven weeks, so a patient stays in the city for the duration rather than travelling in for individual sessions.

Honest boundary: staging, the choice between radiotherapy alone and chemoradiotherapy, and whether any patient is suitable for a clinical trial are all decisions for the treating oncologists after reviewing imaging and pathology. We coordinate that review and the stay; we do not make the treatment decision and we cannot promise any outcome.
Who It May Be Evaluated For

Commonly reviewed indications

Radiation-oncology departments commonly evaluate:

Early-stage NPC

Stage I–II disease treated with definitive radiotherapy alone.

Locally advanced NPC

Stage III–IVa disease treated with concurrent chemoradiotherapy.

Recurrent or metastatic NPC

Re-irradiation, systemic therapy or immunotherapy pathways, reviewed case by case.

Pediatric and young-adult NPC

Rare in this age group, but managed at centers with dedicated pediatric oncology support.

Costs

What NPC treatment costs in China

A course of radiotherapy is priced as a course, not per session:

ItemChina (international dept.)United States (reference)
IMRT courseradiotherapy, per course$10,000 – 25,000$35,000 – 90,000
whole course, billed charges
Concurrent chemotherapyif recommendedadditional, quoted in the hospital’s written estimate$50,000 – 80,000
concurrent cisplatin-based chemoradiation, billed charges
Duration in citytypical treatment period6 – 7 weeks of daily sessionssame protocol duration — daily sessions over 6–7 weeks
Source and scope: derived from a provincial radiotherapy pricing schedule floor and a national cost-of-care study; the range reflects differences in technique and number of fractions. For the US reference, a full IMRT course of 30–35 fractions is listed at $35,000 – 90,000 in US radiation-oncology cost guides; those are billed charges, and insurance-allowed rates for the same course are lower. Last checked 2025–26. These are indicative reference ranges compiled from published hospital fees, public procurement prices and international-patient quotes. They are not quotations: the written estimate you receive from the treating hospital is the final number. Scope, implant choice, ward class and length of stay all move the figure.
Published Outcomes

How do the results compare?

Nasopharyngeal carcinoma is rare in the West and endemic in southern China — so the highest-volume NPC centers in the world are Chinese, and they publish stage-by-stage results:

Stage (IMRT, 5-year overall survival)Sun Yat-sen University Cancer CenterUS (SEER, 2015–2021)
Stage I100%Localized: 86%
Stage II94.3%Regional: 79%
Stage III83.6%Distant: 40% — advanced NPC in China (stage IVa–b) still reaches 70.5%, from the same 868-patient series
Stage III cohort total87.4%
7,081-patient IMRT cohort, 10-year experience
Sources: Sun X. et al., Radiotherapy and Oncology (2014) — 868 non-metastatic NPC patients treated with IMRT at Sun Yat-sen University Cancer Center, stage-wise 5-year overall survival; Zhang M-X. et al., European Journal of Cancer (2015) — 7,081-patient cohort from the same center; American Cancer Society analysis of the US SEER database (diagnoses 2015–2021, latest available). These are published figures, not a head-to-head comparison: SEER stages (localized/regional/distant) do not map exactly onto AJCC stages, and nearly all NPC in China is EBV-related squamous carcinoma while Western series include different pathology mixes. Individual results vary, and survival statistics are not a guarantee of outcome.
The Journey

How we coordinate an NPC case

1
Initial Case Review

You send pathology, MRI/CT of the head and neck, and any prior treatment history; we confirm which radiation-oncology centers fit the case.

2
Costs confirmed in writing

Your records are presented to suitable departments, and you receive a written treatment plan and estimate before committing to anything.

3
Travel & accommodation

Visa invitation letter, flights and a longer-stay apartment near the hospital are arranged before you fly — a radiotherapy course means weeks in the city, not days.

4
Treatment planning

Imaging is reviewed on site, the immobilisation mask is made and the radiotherapy plan is prepared and explained to you through an interpreter.

5
Daily treatment and monitoring

Radiotherapy is delivered daily over six to seven weeks, with weekly review, blood tests and management of side effects such as mucositis.

6
Discharge & follow-up planning

Interpreter-supported discharge, English documents where the hospital provides them, and a surveillance plan that can be continued with your oncologist at home.

Related

Where to go next

Proton therapy →

An alternative radiotherapy modality for selected head-and-neck cases, $30,000–50,000 per course.

Full price list →

Reference ranges for all treatments, side-by-side with US prices.

How it works →

The six-step process from first inquiry to follow-up, with fee timing.

Have a pathology report and staging imaging?

Send the reports and we will tell you which radiation-oncology centers can review the case — and what a course would involve.